-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Diagnosis and Management of Hereditary Hemochromatosis: Lifestyle Modification, Phlebotomy, and Blood Donation

Program: Education Program
Session: Ironing Out the Wrinkles: Managing Iron Overload in Different Clinical Scenarios
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Iron Overload, Education, Diseases, Metabolic Disorders
Saturday, December 7, 2024, 2:00 PM-3:15 PM

Domenico Girelli, MD, PhD

Department of Medicine, University of Verona, Verona, Italy

Disclosures: Girelli: Pharmacosmos: Speakers Bureau; Sanofi: Honoraria, Research Funding; Vifor: Honoraria, Research Funding; Novo Nordisk: Honoraria.

OffLabel Disclosure: The possible role of rusfertide is briefly discussed in the paper. This hepcidin mimetic is still not approved for hemochromatosis.

Previous Presentation | Next Presentation >>